Pharmacoeconomic evaluation of first-line combination therapy with immunotherapy drugs and platinum-containing chemotherapy in adult patients with metastatic non-squamous non-small cell lung cancer
Objective: to evaluate the pharmacoeconomic efficacy of "atezolizumab + bevacizumab + paclitaxel + carboplatin" drug combination compared to "pembrolizumab + pemetrexed + carboplatin" combination in adult patients with non-small cell lung cancer (NSCLC) in the first line of thera...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
IRBIS LLC,
2024-05-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |